Nomir Medical Announces FDA Clearance for Noveon NaiLaser

Press release: Nomir Medical Announces FDA Clearance for Noveon NaiLaser Quote: WOODMERE, N.Y., March 13, 2014; Nomir Medical Technologies, Inc., the world leader in antimicrobial photobiology, today announced that the US Food and Drug Administration has granted clearance to the company’s Noveon NaiLaser for the treatment of onychomycosis (toenail fungus). (See clearance below) Jack Kay, Nomir CEO, explained, “We developed the Noveon® NaiLaser™ to meet the needs of physicians for a safer, more effective treatment option for toenail fungus sufferers, with an ergonomic, hands-free design to maximize doctor comfort and minimize labor costs”

See the article here:
Nomir Medical Announces FDA Clearance for Noveon NaiLaser

Previous post:

Next post: